Turn Therapeutics Inc.
(TTRX)Financial Statements · SEC EDGAR XBRL
Net Income
-$3.2M
-80.6%
EPS
$-0.12
-71.4%
Op. Income
-$5.9M
-226.0%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Operating Expenses & Income
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)